Indicated as an adjunct to diet and exercise to improve glycemic control in patients with type 2 diabetes (non-insulin dependent diabetes mellitus, NIDDM). Pioglitazone HCl is indicated for ...

Pioglitazone and SGLT2 inhibitors as add-ons to insulin therapy were more effective for lowing HbA1c, fasting plasma glucose and insulin dose requirements in patients with type 2 diabetes than insulin ...

Details concerning the Pioglitazone Hydrochloride combination medication encompass its pricing as well as its availability in various forms, including tablets, capsules, syrups, creams, gels, ...

On 20 September 2007 the Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion, recommending granting a marketing authorisation for the medicinal product Pioglitazone / ...

Silver Spring, MD - The US Food and Drug Administration (FDA) today approved the first generic version of pioglitazone hydrochloride (Actos, Takeda Pharmaceuticals), which is used to improve blood ...

HONOLULU, HI—Patients with a prior stroke or TIA who have prediabetes detected using widely available clinical assessments seem to derive a benefit from pioglitazone, post hoc analysis of the IRIS ...

August 15, 2007 (Rockville, MD) - At the FDA's behest, GlaxoSmithKline and Takeda will be adding black-box warnings to their thiazolidinedione drugs for type 2 diabetes-- rosiglitazone (Avandia) and ...

The protective effect of pioglitazone on type 2 diabetes prevention observed in adults with impaired glucose tolerance diminishes in the months after discontinuing therapy, with participants randomly ...

Nonalcoholic steatohepatitis is a common liver disease that can progress to cirrhosis. Currently, there is no established treatment for this disease. We randomly assigned 247 adults with nonalcoholic ...

Zydus Cadila has got the USFDA approval for marketing Pioglitazone, an anti-diabetes drug used in Type 2 diabetes. Pioglitazone Hydrochloride, acts as an insulin sensitizer and causes the insulin ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Drug regulators ...